BiosanaPharma announces the launch of its Continuous Manufacturing licensing & implementation offering for the downstream processing of biologics

BiosanaPharma and Alvotech close deal on omalizumab biosimilar

Simplifying the bioprocessing journey

One Virtual Biotech's Strategy

BiosanaPharma announces successful phase I of omalizumab biosimilar

BiosanaPharma and A*STAR’s Bioprocessing Technology Institute collaborate to advance continuous biomanufacturing